
Jerome Jackson Jr.
Examiner (ID: 15347, Phone: (571)272-1730 , Office: P/2815 )
| Most Active Art Unit | 2815 |
| Art Unit(s) | 2503, 2815, 2899, 2811 |
| Total Applications | 2143 |
| Issued Applications | 1551 |
| Pending Applications | 52 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6912321
[patent_doc_number] => 20050176079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Polypeptide bioconjugates, methods of making the bioconjugates and assays employing the bioconjugates'
[patent_app_type] => utility
[patent_app_number] => 10/773274
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7805
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773274 | Polypeptide bioconjugates, methods of making the bioconjugates and assays employing the bioconjugates | Feb 8, 2004 | Abandoned |
Array
(
[id] => 5040656
[patent_doc_number] => 20070092938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Diagnostics for sars virus'
[patent_app_type] => utility
[patent_app_number] => 10/564617
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13440
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092938.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564617 | Diagnostics for sars virus | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7372121
[patent_doc_number] => 20040219167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Herpes viruses for immune modulation'
[patent_app_type] => new
[patent_app_number] => 10/766897
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9827
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10766897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/766897 | Herpes viruses for immune modulation | Jan 29, 2004 | Issued |
Array
(
[id] => 581092
[patent_doc_number] => 07449321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Molecules, compositions, methods and kits for applications associated with flaviviruses'
[patent_app_type] => utility
[patent_app_number] => 10/769565
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 18728
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449321.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769565 | Molecules, compositions, methods and kits for applications associated with flaviviruses | Jan 28, 2004 | Issued |
Array
(
[id] => 5666611
[patent_doc_number] => 20060171961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Composition and method for preventing or treating a virus infection'
[patent_app_type] => utility
[patent_app_number] => 10/541771
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7781
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541771 | Composition and method for preventing or treating a virus infection | Jan 13, 2004 | Issued |
Array
(
[id] => 7325138
[patent_doc_number] => 20040138137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Alloferons - immunomodulatory peptides'
[patent_app_type] => new
[patent_app_number] => 10/742864
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8734
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10742864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/742864 | Alloferons—immunomodulatory peptides | Dec 22, 2003 | Issued |
Array
(
[id] => 5661080
[patent_doc_number] => 20060251676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Hpv-16 and-18 l1 vlp vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/540099
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6714
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251676.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540099
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540099 | Hpv-16 and-18 l1 vlp vaccine | Dec 17, 2003 | Abandoned |
Array
(
[id] => 334005
[patent_doc_number] => 07507416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Live recombined vaccines injected with adjuvant'
[patent_app_type] => utility
[patent_app_number] => 10/735429
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 10634
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507416.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735429 | Live recombined vaccines injected with adjuvant | Dec 11, 2003 | Issued |
Array
(
[id] => 4778310
[patent_doc_number] => 20080286308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods'
[patent_app_type] => utility
[patent_app_number] => 10/581184
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6541
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581184 | Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods | Dec 11, 2003 | Abandoned |
Array
(
[id] => 540891
[patent_doc_number] => 07169585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Papillomavirus vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/732345
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 10962
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169585.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732345 | Papillomavirus vaccine | Dec 10, 2003 | Issued |
Array
(
[id] => 7424863
[patent_doc_number] => 20040208900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS'
[patent_app_type] => new
[patent_app_number] => 10/730029
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 31527
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10730029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/730029 | Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS | Dec 8, 2003 | Issued |
Array
(
[id] => 220664
[patent_doc_number] => 07608274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Therapeutic processes and useful compositions therefor'
[patent_app_type] => utility
[patent_app_number] => 10/470611
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10588
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470611 | Therapeutic processes and useful compositions therefor | Dec 7, 2003 | Issued |
Array
(
[id] => 5198736
[patent_doc_number] => 20070298054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Highly Safe Smallpox Vaccine Virus and Vaccinia Virus Vector'
[patent_app_type] => utility
[patent_app_number] => 10/581495
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8419
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581495
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581495 | Highly safe smallpox vaccine virus and vaccinia virus vector | Dec 4, 2003 | Issued |
Array
(
[id] => 7322416
[patent_doc_number] => 20040137008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Non-splicing variants of gp350/220'
[patent_app_type] => new
[patent_app_number] => 10/722050
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10438
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722050 | Non-splicing variants of gp350/220 | Nov 24, 2003 | Abandoned |
Array
(
[id] => 7252620
[patent_doc_number] => 20050074888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/723798
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13534
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10723798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/723798 | Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same | Nov 24, 2003 | Abandoned |
Array
(
[id] => 82687
[patent_doc_number] => 07740863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Recombinant vaccine against West Nile Virus'
[patent_app_type] => utility
[patent_app_number] => 10/714781
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 23
[patent_no_of_words] => 30692
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/740/07740863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714781
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714781 | Recombinant vaccine against West Nile Virus | Nov 16, 2003 | Issued |
Array
(
[id] => 5084964
[patent_doc_number] => 20070275015
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-11-29
[patent_title] => 'WEST NILE VIRUS VACCINE'
[patent_app_type] => utility
[patent_app_number] => 10/715868
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5782
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0275/20070275015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715868 | West nile virus vaccine | Nov 16, 2003 | Issued |
Array
(
[id] => 5084964
[patent_doc_number] => 20070275015
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-11-29
[patent_title] => 'WEST NILE VIRUS VACCINE'
[patent_app_type] => utility
[patent_app_number] => 10/715868
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5782
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0275/20070275015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715868 | West nile virus vaccine | Nov 16, 2003 | Issued |
Array
(
[id] => 880530
[patent_doc_number] => 07355033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Screening for West Nile Virus antiviral therapy'
[patent_app_type] => utility
[patent_app_number] => 10/706892
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 35792
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706892 | Screening for West Nile Virus antiviral therapy | Nov 12, 2003 | Issued |
Array
(
[id] => 6905488
[patent_doc_number] => 20050100883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Peptide-based diagnostic reagents for SARS'
[patent_app_type] => utility
[patent_app_number] => 10/712812
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13132
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712812 | Peptide-based diagnostic reagents for SARS | Nov 11, 2003 | Abandoned |